Jared Haase
Stock Analyst at William Blair
(4.16)
# 1,547
Out of 5,023 analysts
69
Total ratings
69%
Success rate
16.3%
Average return
Main Sectors:
Stocks Rated by Jared Haase
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LFCR Lifecore Biomedical | Downgraded: Hold | n/a | $6.54 | - | 3 | Sep 29, 2026 | |
| CRL Charles River Laboratories International | Reiterated: Buy | n/a | $290.19 | - | 2 | Sep 24, 2026 | |
| ADUS Addus HomeCare | Reiterated: Buy | n/a | $111.27 | - | 6 | Sep 14, 2026 | |
| LH Labcorp Holdings | Reiterated: Buy | n/a | $308.49 | - | 2 | Sep 11, 2026 | |
| FTRE Fortrea Holdings | Reiterated: Hold | n/a | $20.00 | - | 4 | Sep 10, 2026 | |
| INNV InnovAge Holding | Reiterated: Hold | n/a | $8.96 | - | 5 | Sep 9, 2026 | |
| CON Concentra Group Holdings Parent | Reiterated: Buy | n/a | $35.65 | - | 3 | Sep 8, 2026 | |
| USPH U.S. Physical Therapy | Reiterated: Hold | n/a | $83.72 | - | 7 | Aug 14, 2026 | |
| AVAH Aveanna Healthcare Holdings | Reiterated: Buy | n/a | $12.59 | - | 8 | Aug 13, 2026 | |
| DNA Ginkgo Bioworks Holdings | Reiterated: Sell | n/a | $12.35 | - | 2 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $9.36 | - | 1 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $119.80 | - | 8 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $39.24 | - | 5 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $60.25 | - | 6 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $162.02 | - | 1 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $258.21 | - | 1 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $233.33 | - | 1 | Jul 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $599.47 | - | 1 | Jul 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.9333 | - | 3 | Jul 2, 2026 |
Lifecore Biomedical
Sep 29, 2026
Downgraded: Hold
Price Target: n/a
Current: $6.54
Upside: -
Charles River Laboratories International
Sep 24, 2026
Reiterated: Buy
Price Target: n/a
Current: $290.19
Upside: -
Addus HomeCare
Sep 14, 2026
Reiterated: Buy
Price Target: n/a
Current: $111.27
Upside: -
Labcorp Holdings
Sep 11, 2026
Reiterated: Buy
Price Target: n/a
Current: $308.49
Upside: -
Fortrea Holdings
Sep 10, 2026
Reiterated: Hold
Price Target: n/a
Current: $20.00
Upside: -
InnovAge Holding
Sep 9, 2026
Reiterated: Hold
Price Target: n/a
Current: $8.96
Upside: -
Concentra Group Holdings Parent
Sep 8, 2026
Reiterated: Buy
Price Target: n/a
Current: $35.65
Upside: -
U.S. Physical Therapy
Aug 14, 2026
Reiterated: Hold
Price Target: n/a
Current: $83.72
Upside: -
Aveanna Healthcare Holdings
Aug 13, 2026
Reiterated: Buy
Price Target: n/a
Current: $12.59
Upside: -
Ginkgo Bioworks Holdings
Aug 13, 2026
Reiterated: Sell
Price Target: n/a
Current: $12.35
Upside: -
Aug 5, 2026
Reiterated: Hold
Price Target: n/a
Current: $9.36
Upside: -
Aug 5, 2026
Reiterated: Buy
Price Target: n/a
Current: $119.80
Upside: -
Aug 5, 2026
Reiterated: Buy
Price Target: n/a
Current: $39.24
Upside: -
Jul 31, 2026
Reiterated: Buy
Price Target: n/a
Current: $60.25
Upside: -
Jul 29, 2026
Reiterated: Buy
Price Target: n/a
Current: $162.02
Upside: -
Jul 28, 2026
Reiterated: Buy
Price Target: n/a
Current: $258.21
Upside: -
Jul 23, 2026
Reiterated: Buy
Price Target: n/a
Current: $233.33
Upside: -
Jul 23, 2026
Reiterated: Hold
Price Target: n/a
Current: $599.47
Upside: -
Jul 2, 2026
Rated: Hold
Price Target: n/a
Current: $0.9333
Upside: -